NCT01250678View on ClinicalTrials.gov

Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2014

Conditions
Multiple SclerosisCognitive Impairment
Trial Locations (1)

9007

Cantonal Hospital of Saint Gallen, Sankt Gallen

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Cantonal Hospital of St. Gallen

OTHER